SCHEMBL22888554

SCHEMBL22888554

NC(=O)c1cc2c(cn1)cnn2CC(F)(F)F

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RIPK1 Q13546 2/20 0.40
KMT2A Q03164 1/20 0.39
SRC P12931 1/20 0.37
LCK P06239 1/20 0.35
P2RX3 P56373 1/20 0.34
P2RX2 Q9UBL9 1/20 0.34
KMO O15229 5/20 0.34
CCNA2 P20248 3/20 0.34
CDK2 P24941 3/20 0.34
CCNA1 P78396 3/20 0.34
PIK3CA P42336 1/20 0.33
MAPK1 P28482 1/20 0.33
NT5E P21589 1/20 0.33
NR1I2 O75469 1/20 0.33
KCNH2 Q12809 1/20 0.33
GRM2 Q14416 1/20 0.33
HTR2A P28223 1/20 0.33
HTR2C P28335 1/20 0.33
HTR2B P41595 1/20 0.33
SIRT6 Q8N6T7 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25338800 0.81 RIPK1 (0.40) RIPK1P2RX3P2RX2KMOPIK3CA
SCHEMBL22888344 0.81 NOTUM (0.40) RIPK1KMT2ALCKKMOHTR2A
SCHEMBL25337551 0.80 RIPK1 (0.40) RIPK1NT5E
SCHEMBL25337436 0.79 RIPK1 (0.39) RIPK1NT5E
SCHEMBL24851750 0.79 PDPK1 (0.34) RIPK1NT5EHTR2AHTR2CHTR2B
SCHEMBL19659345 0.78 HTR2A (0.37) RIPK1KMT2ALCKKMOHTR2A
SCHEMBL20262385 0.78 RIPK1 (0.49) RIPK1KMO
SCHEMBL30587568 0.78 RIPK1 (0.48) RIPK1KMT2ALCKMAPK1SIRT6
SCHEMBL29989131 0.77 ASPH (0.41) RIPK1P2RX3P2RX2KMOMAPK1
SCHEMBL24851097 0.76 HTR2A (0.35) KMOCDK2NT5EHTR2AHTR2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3760625-A1 BICYCLIC LACTAMS AS RECEPTOR-INTERACTING PROTEIN-1 (RIP1) KINASE INHIBITORS FOR TREATING E.G. INFLAMMATORY DISEASES F. Hoffmann-La Roche AG (CH) 2021-01-06 EP disclosed